european guidelines for breast cancer screening

Release time ：Dec-21,2024

The European breast cancer screening guidelines underscore the significance of early diagnosis, typically advising women to commence regular screenings at the age of 50. Early detection and intervention can markedly enhance survival rates and diminish the risk of mortality. The primary screening modalities include mammography (also referred to as mammary target examination) and clinical breast examination.

The guidelines suggest biennial mammography screenings, a frequency deemed appropriate for women between the ages of 50 and 69. For those above 70, continued screening is recommended if they are in good health and have a sufficiently long life expectancy to benefit from it. Additionally, clinical breast examinations should be integrated into routine health check-ups, conducted by qualified healthcare professionals to aid in identifying any anomalies.

In conclusion, adhering to the European breast cancer screening guidelines and engaging in regular screenings is of paramount importance. This approach not only facilitates the early identification of abnormalities but also enhances the efficacy of treatment. Consequently, women are encouraged to actively engage in screening programs and to seek timely medical consultation upon detecting any breast irregularities.